Drivers of Non-First-Line Antibiotic Prescribing for Acute Respiratory Infections in Urgent Care

BACKGROUND/OBJECTIVE: National guidelines provide recommendations for first-line therapy (FLT) for acute respiratory infections (ARIs). Sociodemographic differences in FLT for ARIs have been described. This study identified and categorized reasons for non-FLT for ARIs in pediatric urgent care (PUC) and evaluated whether these reasons differ across sociodemographic groups. METHODS: We conducted a retrospective chart review of PUC encounters for patients ages 6 months to 19 years diagnosed with acute otitis media, pharyngitis, community-acquired pneumonia, or acute bacterial rhinosinusitis between April 2023 and March 2024 who received an oral antibiotic. We categorized reasons for non-FLT using predefined groups: penicillin allergy label (PAL), treatment failure, new adverse effect of FLT, recent antibiotic exposure, other clinical rationale such as additional diagnoses or concern for atypical infections, family request, or no documented reason. Sociodemographic characteristics were compared across categories. RESULTS: Among 18,507 ARI encounters, 1,506 (8.1%) received non-FLT. PALs accounted for 58.8% (n=886) of non-FLT prescribing. Recent antibiotic exposure was the second most common reason (n=265, 17.6%); however, only 9.8% of therapy escalations were guideline-concordant. Family requests accounted for 4.3% of non-FLT use. Non-FLT were more common in White children, those on Commercial insurance, and children who speak English as their primary language compared to their socioeconomic counterparts. No differences in reasons for non-FLT were observed by race, insurance type, or preferred language. Hispanic patients had a higher proportion of PAL-related non-FLT (71.4%) compared with non-Hispanic patients (58.3%). CONCLUSION: PALs and escalation of therapy were the predominant drivers of non-FLT prescribing in PUC. Family requests played a minimal role. Although we observed differences of non-FLT by race, language, and insurance as described previously, we did not observe differences in reasons for non-FLT between the different socioeconomic groups. Interventions aimed at improving PAL accuracy and guideline-concordant escalation practices may enhance appropriate FLT use.

Authors

Institutions

Publication Details

Journal
Journal of the Pediatric Infectious Diseases Society
Published
2026-09-01
DOI
https://doi.org/10.1093/jpids/piag086
Primary Topic
Antibiotic Use and Resistance
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Drivers of Non-First-Line Antibiotic Prescribing for Acute Respiratory Infections in Urgent Care

Amanda C. Nedved, Rana E. El Feghaly, Jennifer McKinsey, Brian Lee et al.
Journal of the Pediatric Infectious Diseases Society
Antibiotic Use and Resistance
article

Drivers of Non-First-Line Antibiotic Prescribing for Acute Respiratory Infections in Urgent Care

Amanda C. Nedved, Rana E. El Feghaly, Jennifer McKinsey, Brian Lee, Nicita Anand
article en

Abstract

BACKGROUND/OBJECTIVE: National guidelines provide recommendations for first-line therapy (FLT) for acute respiratory infections (ARIs). Sociodemographic differences in FLT for ARIs have been described. This study identified and categorized reasons for non-FLT for ARIs in pediatric urgent care (PUC) and evaluated whether these reasons differ across sociodemographic groups. METHODS: We conducted a retrospective chart review of PUC encounters for patients ages 6 months to 19 years diagnosed with acute otitis media, pharyngitis, community-acquired pneumonia, or acute bacterial rhinosinusitis between April 2023 and March 2024 who received an oral antibiotic. We categorized reasons for non-FLT using predefined groups: penicillin allergy label (PAL), treatment failure, new adverse effect of FLT, recent antibiotic exposure, other clinical rationale such as additional diagnoses or concern for atypical infections, family request, or no documented reason. Sociodemographic characteristics were compared across categories. RESULTS: Among 18,507 ARI encounters, 1,506 (8.1%) received non-FLT. PALs accounted for 58.8% (n=886) of non-FLT prescribing. Recent antibiotic exposure was the second most common reason (n=265, 17.6%); however, only 9.8% of therapy escalations were guideline-concordant. Family requests accounted for 4.3% of non-FLT use. Non-FLT were more common in White children, those on Commercial insurance, and children who speak English as their primary language compared to their socioeconomic counterparts. No differences in reasons for non-FLT were observed by race, insurance type, or preferred language. Hispanic patients had a higher proportion of PAL-related non-FLT (71.4%) compared with non-Hispanic patients (58.3%). CONCLUSION: PALs and escalation of therapy were the predominant drivers of non-FLT prescribing in PUC. Family requests played a minimal role. Although we observed differences of non-FLT by race, language, and insurance as described previously, we did not observe differences in reasons for non-FLT between the different socioeconomic groups. Interventions aimed at improving PAL accuracy and guideline-concordant escalation practices may enhance appropriate FLT use.

Journal of the Pediatric Infectious Diseases Society
Children's Mercy Hospital (US), University of Missouri–Kansas City (US)
Openalex Percentile: Top 10%
Antibiotic Use and Resistance
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.